Пошуковий запит: <.>II=ЕУ12/2020/42/2<.> |
Загальна кількість знайдених документів : 13
Показані документи с 1 за 13 |
1.
| Shvets Yu. V. Human microbiota and effectiveness of cancer chemotherapy/Yu. V. Shvets, N. Yu. Lukianova, V. F. Chekhun // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.82-93
|
2.
| Nanog as prognostic factor of prostate cancer course/T. V. Zadvornyi [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.94-100
|
3.
| Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin/H. Lamdan [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.101-108
|
4.
| Antonenko S. V. Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells/S. V. Antonenko, G. D. Telegeev // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.109-114
|
5.
| Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma/K. V. Onyshchenko [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.115-119
|
6.
| Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model/M. V. Stegantseva [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.120-125
|
7.
| Peculiarities of abnormal karyotypes formation in therapy-related acute leukemias/S. V. Andreieva [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.126-129
|
8.
| HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer/P. Bialik [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.130-134
|
9.
| Pankaj D. Clinicopathological correlation of the expression of excision repair cross complementation group 1 (ERCC1) in oral cavity squamous cell carcinomas: an immunohistochemical study/D. Pankaj, V. Guddattu, M. C. Solomon // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.135-139
|
10.
| Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer/S. A. Lyalkin [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.140-143
|
11.
| Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy/T. Perekhrestenko [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.144-147
|
12.
| Temozolomide in glioblastoma treatment: 15-year clinical experience and analysis of its efficacy/O. Ya. Glavatskyi [et al.] // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.148-156
|
13.
| Kliusov O. M. Specialized care provided to patients with rectal cancer in Kyiv city/O. M. Kliusov // Experimental Oncology. -К., 2020. т.Том 42,N N 2.-С.157-160
|
|
|
Періодичних видань
Стандартний